Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Florian van Bömmel

Biographic Data

ID7794145
NAMEFlorian van Bömmel
GIVEN NAMESFlorian
FAMILY NAMEvan Bömmel
SIGNATUREVAN BÖMMEL F
AFFILIATIONSLeipzig University
ORCID0000-0003-2679-0672
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2024
H-INDEX0
  • Experience and impact of stigma in people with chronic hepatitis B

    Open Access•Mondher Toumi, Jack Wallace et al.•ARTICLE•BMC Public Health•2024

    CHB-related social and self-stigma are widely prevalent and affect many aspects of life. A functional cure for hepatitis B may reduce social and self-stigma and substantially improve the health-related quality of life of people with CHB. Incorporating stigma into guidelines along with infectivity considerations may broaden the patient groups who should receive treatment

  • Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019

    Open Access•Anna Maisa, Christian Kollan et al.•ARTICLE•Frontiers in Public Health•2021

    Background: Germany is a low prevalence country for hepatitis B virus (HBV) infection with higher prevalence in vulnerable groups. The number of treated chronic hepatitis B (CHB) patients is unknown. We aimed to determine the number of CHB patients treated with nucleos(t)ide analogs (NUCs), the treatment costs within the statutory health insurance (SHI) in Germany and per patient per month. Methods: Data on pharmacy bills of NUCs to patients with…

No prominent works on this page.

  • Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019

    Open Access•Anna Maisa, Christian Kollan et al.•ARTICLE•Frontiers in Public Health•2021

    Background: Germany is a low prevalence country for hepatitis B virus (HBV) infection with higher prevalence in vulnerable groups. The number of treated chronic hepatitis B (CHB) patients is unknown. We aimed to determine the number of CHB patients treated with nucleos(t)ide analogs (NUCs), the treatment costs within the statutory health insurance (SHI) in Germany and per patient per month. Methods: Data on pharmacy bills of NUCs to patients with…

  • Experience and impact of stigma in people with chronic hepatitis B

    Open Access•Mondher Toumi, Jack Wallace et al.•ARTICLE•BMC Public Health•2024

    CHB-related social and self-stigma are widely prevalent and affect many aspects of life. A functional cure for hepatitis B may reduce social and self-stigma and substantially improve the health-related quality of life of people with CHB. Incorporating stigma into guidelines along with infectivity considerations may broaden the patient groups who should receive treatment

Family medicine (2 works) · Hepatitis B Virus Studies (2 works) · Hepatitis C virus research (2 works) · Medicine (2 works) · Adefovir (1 work) · Biostatistics (1 work) · Chronic hepatitis (1 work) · Clinical Psychology (1 work) · Clinical Psychology (1 work) · Entecavir (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae